Chris Moreau
Vorstandsvorsitzender bei ALGERNON PHARMACEUTICALS INC.
Vermögen: 93 047 $ am 30.04.2024
Aktive Positionen von Chris Moreau
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ALGERNON PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 13.05.2020 | - |
| Vorstandsvorsitzender | 01.03.2018 | - | |
| Investor Relations Kontakt | - | - |
Karriereverlauf von Chris Moreau
Ehemalige bekannte Positionen von Chris Moreau
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| QUEBEC PEGMATITE HOLDINGS CORP. | Direktor/Vorstandsmitglied | 08.02.2019 | 26.11.2020 |
| Präsident | 08.02.2019 | 24.07.2019 | |
Luminor Medical Technologies, Inc.
 Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | 02.06.2011 | 21.04.2016 |
| Vorstandsvorsitzender | 01.02.2007 | 21.04.2016 | |
| Investor Relations Kontakt | 31.03.2011 | 21.04.2016 | |
| Präsident | 01.02.2007 | 21.04.2016 | |
Nash Pharmaceuticals, Inc.
 Nash Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nash Pharmaceuticals, Inc. engages in the research and development of repurposed therapeutic drugs and pharmaceutical products. Its focus areas include non-alcoholic steatohepatitis, chronic kidney disease, and inflammatory bowel disease. The company is headquartered in Vancouver, Canada. | Vorstandsvorsitzender | - | - |
| Advansis Capital Corp. | Präsident | - | - |
Statistik
International
| Kanada | 5 |
| 2 |
Operativ
| Director/Board Member | 3 |
| Chief Executive Officer | 3 |
| President | 3 |
Sektoral
| Commercial Services | 2 |
| Electronic Technology | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada. | Commercial Services |
| Advansis Capital Corp. | |
| Algernon Pharmaceuticals, Inc. | |
First Responder Technologies, Inc.
 First Responder Technologies, Inc. Aerospace & DefenseElectronic Technology First Responder Technologies, Inc. is in the process of exploring business opportunities. The company was founded on January 27, 2017 and is headquartered in Vancouver, Canada. | Electronic Technology |
Nash Pharmaceuticals, Inc.
Nash Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nash Pharmaceuticals, Inc. engages in the research and development of repurposed therapeutic drugs and pharmaceutical products. Its focus areas include non-alcoholic steatohepatitis, chronic kidney disease, and inflammatory bowel disease. The company is headquartered in Vancouver, Canada. | Health Technology |
- Börse
- Insiders
- Chris Moreau
- Erfahrung
